Utility of ctDNA in assessment of treatment response in patients with Recurrent/Metastatic Endometrial Cancer and Recurrent/Platinum-Resista Published Date March 20, 2024 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen